Global Pneumonia Vaccine Market to Reach $12.67B by 2034, Driven by Expanded Immunization & Next-Gen Vaccines What Are Pneumonia Vaccines? Pneumonia vaccines are critical biological preparations that protect against infections caused by Streptococcus pneumoniae and related pathogens that can lead to pneumonia, meningitis, and sepsis. These vaccines work by stimulating the immune system to produce antibodies, with two main types dominating the market: Pneumococcal conjugate vaccines (PCV13) - Targets 13 serotypes with enhanced immune response Pneumococcal polysaccharide vaccines (PPSV23) - Covers 23 serotypes but with weaker immune memory The vaccines have become essential tools in global public health, particularly for vulnerable populations like children and the elderly Visit website https://www.intelmarketresearch.com/download-free-sample/34443/pneumonia-vaccine-market